Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Killer immunoglobulin-like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment-free remission.

Dumas PY, Bérard E, Bréal C, Dulucq S, Réa D, Nicolini F, Forcade E, Dufossée M, Pasquet JM, Turcq B, Bidet A, Milpied N, Déchanet-Merville J, Lafarge X, Etienne G, Mahon FX; French Intergroup in Chronic Myeloid Leukemia.

Cancer Med. 2019 Jul 9. doi: 10.1002/cam4.2371. [Epub ahead of print]

2.

Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.

Kaminski H, Jarque M, Halfon M, Taton B, Di Ascia L, Pfirmann P, Visentin J, Garrigue I, Déchanet-Merville J, Moreau JF, Crespo E, Montero N, Melilli E, Meneghini M, Pascual M, Couzi L, Manuel O, Bestard O, Merville P.

J Infect Dis. 2019 Apr 26. pii: jiz194. doi: 10.1093/infdis/jiz194. [Epub ahead of print]

PMID:
31157865
3.

Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

Pizzolato G, Kaminski H, Tosolini M, Franchini DM, Pont F, Martins F, Valle C, Labourdette D, Cadot S, Quillet-Mary A, Poupot M, Laurent C, Ysebaert L, Meraviglia S, Dieli F, Merville P, Milpied P, Déchanet-Merville J, Fournié JJ.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11906-11915. doi: 10.1073/pnas.1818488116. Epub 2019 May 22.

PMID:
31118283
4.

Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells.

Di Lorenzo B, Simões AE, Caiado F, Tieppo P, Correia DV, Carvalho T, da Silva MG, Déchanet-Merville J, Schumacher TN, Prinz I, Norell H, Ravens S, Vermijlen D, Silva-Santos B.

Cancer Immunol Res. 2019 Apr;7(4):552-558. doi: 10.1158/2326-6066.CIR-18-0647. Epub 2019 Mar 20.

PMID:
30894378
5.

Recruitment of CXCR3+ T cells into injured tissues in adult IgA vasculitis patients correlates with disease activity.

Audemard-Verger A, Pillebout E, Jamin A, Berthelot L, Aufray C, Martin B, Sannier A, Daugas E, Déchanet-Merville J, Richard Y, Monteiro R, Lucas B.

J Autoimmun. 2019 May;99:73-80. doi: 10.1016/j.jaut.2019.01.012. Epub 2019 Feb 8.

PMID:
30745186
6.

Human Vγ9Vδ2 T Lymphocytes in the Immune Response to P. falciparum Infection.

Howard J, Zaidi I, Loizon S, Mercereau-Puijalon O, Déchanet-Merville J, Mamani-Matsuda M.

Front Immunol. 2018 Nov 27;9:2760. doi: 10.3389/fimmu.2018.02760. eCollection 2018. Review.

7.

Peripheral clonal selection shapes the human γδ T-cell repertoire.

Di Lorenzo B, Déchanet-Merville J, Silva-Santos B.

Cell Mol Immunol. 2017 Sep;14(9):733-735. doi: 10.1038/cmi.2017.51. Epub 2017 Aug 7. No abstract available.

8.

Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.

Lawand M, Déchanet-Merville J, Dieu-Nosjean MC.

Front Immunol. 2017 Jun 30;8:761. doi: 10.3389/fimmu.2017.00761. eCollection 2017. Review.

9.

The Antigen-Presenting Potential of Vγ9Vδ2 T Cells During Plasmodium falciparum Blood-Stage Infection.

Howard J, Loizon S, Tyler CJ, Duluc D, Moser B, Mechain M, Duvignaud A, Malvy D, Troye-Blomberg M, Moreau JF, Eberl M, Mercereau-Puijalon O, Déchanet-Merville J, Behr C, Mamani-Matsuda M.

J Infect Dis. 2017 May 15;215(10):1569-1579. doi: 10.1093/infdis/jix149.

PMID:
28368498
10.

Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2.

Marlin R, Pappalardo A, Kaminski H, Willcox CR, Pitard V, Netzer S, Khairallah C, Lomenech AM, Harly C, Bonneville M, Moreau JF, Scotet E, Willcox BE, Faustin B, Déchanet-Merville J.

Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3163-3168. doi: 10.1073/pnas.1621052114. Epub 2017 Mar 7.

11.

γδ T Cell-Mediated Immunity to Cytomegalovirus Infection.

Khairallah C, Déchanet-Merville J, Capone M.

Front Immunol. 2017 Feb 9;8:105. doi: 10.3389/fimmu.2017.00105. eCollection 2017. Review.

12.

Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states.

Furman D, Chang J, Lartigue L, Bolen CR, Haddad F, Gaudilliere B, Ganio EA, Fragiadakis GK, Spitzer MH, Douchet I, Daburon S, Moreau JF, Nolan GP, Blanco P, Déchanet-Merville J, Dekker CL, Jojic V, Kuo CJ, Davis MM, Faustin B.

Nat Med. 2017 Feb;23(2):174-184. doi: 10.1038/nm.4267. Epub 2017 Jan 16.

13.

Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1.

Garcia-Beltran WF, Hölzemer A, Martrus G, Chung AW, Pacheco Y, Simoneau CR, Rucevic M, Lamothe-Molina PA, Pertel T, Kim TE, Dugan H, Alter G, Dechanet-Merville J, Jost S, Carrington M, Altfeld M.

Nat Immunol. 2016 Sep;17(9):1067-74. doi: 10.1038/ni.3513. Epub 2016 Jul 25.

14.

Easier Control of Late-Onset Cytomegalovirus Disease Following Universal Prophylaxis Through an Early Antiviral Immune Response in Donor-Positive, Recipient-Negative Kidney Transplants.

Kaminski H, Couzi L, Garrigue I, Moreau JF, Déchanet-Merville J, Merville P.

Am J Transplant. 2016 Aug;16(8):2384-94. doi: 10.1111/ajt.13781. Epub 2016 Apr 8. Erratum in: Am J Transplant. 2017 Feb;17 (2):588-589.

15.

Cytomegalovirus-Induced γδ T Cells During Rejection: An Ambivalent T Cell.

Bachelet T, Merville P, Dechanet-Merville J, Couzi L.

Am J Transplant. 2016 Jan;16(1):368-9. doi: 10.1111/ajt.13568. No abstract available.

16.

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers.

Krzywinska E, Allende-Vega N, Cornillon A, Vo DN, Cayrefourcq L, Panabieres C, Vilches C, Déchanet-Merville J, Hicheri Y, Rossi JF, Cartron G, Villalba M.

EBioMedicine. 2015 Aug 13;2(10):1364-76. doi: 10.1016/j.ebiom.2015.08.021. eCollection 2015 Oct.

17.

Editorial: "Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives".

Kabelitz D, Déchanet-Merville J.

Front Immunol. 2015 Jul 21;6:371. doi: 10.3389/fimmu.2015.00371. eCollection 2015. No abstract available.

18.

[Immunomonitoring for cytomegalovirus infection in kidney transplantation: Development and prospects].

Kaminski H, Couzi L, Déchanet-Merville J, Merville P.

Nephrol Ther. 2015 Nov;11(6):465-73. doi: 10.1016/j.nephro.2015.03.005. Epub 2015 Jul 21. Review. French.

PMID:
26206770
19.

Phosphoantigen Burst upon Plasmodium falciparum Schizont Rupture Can Distantly Activate Vγ9Vδ2 T Cells.

Guenot M, Loizon S, Howard J, Costa G, Baker DA, Mohabeer SY, Troye-Blomberg M, Moreau JF, Déchanet-Merville J, Mercereau-Puijalon O, Mamani-Matsuda M, Behr C.

Infect Immun. 2015 Oct;83(10):3816-24. doi: 10.1128/IAI.00446-15. Epub 2015 Jul 13.

20.

TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance.

Guerville F, Daburon S, Marlin R, Lartigue L, Loizon S, Pitard V, Couzi L, Moreau JF, Déchanet-Merville J, Faustin B.

Oncoimmunology. 2015 Feb 3;4(5):e1003011. eCollection 2015 May.

21.

Surveillance of γδ T Cells Predicts Cytomegalovirus Infection Resolution in Kidney Transplants.

Kaminski H, Garrigue I, Couzi L, Taton B, Bachelet T, Moreau JF, Déchanet-Merville J, Thiébaut R, Merville P.

J Am Soc Nephrol. 2016 Feb;27(2):637-45. doi: 10.1681/ASN.2014100985. Epub 2015 Jun 8.

22.

Two-year post-transplantation cytomegalovirus DNAemia in asymptomatic kidney transplant recipients: incidence, risk factors, and outcome.

Viot B, Garrigue I, Taton B, Bachelet T, Moreau JF, Dechanet-Merville J, Merville P, Couzi L.

Transpl Infect Dis. 2015 Aug;17(4):497-509. doi: 10.1111/tid.12408. Epub 2015 Jul 7.

PMID:
26052675
23.

γδ T cells confer protection against murine cytomegalovirus (MCMV).

Khairallah C, Netzer S, Villacreces A, Juzan M, Rousseau B, Dulanto S, Giese A, Costet P, Praloran V, Moreau JF, Dubus P, Vermijlen D, Déchanet-Merville J, Capone M.

PLoS Pathog. 2015 Mar 6;11(3):e1004702. doi: 10.1371/journal.ppat.1004702. eCollection 2015 Mar.

24.

Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation.

Couzi L, Pitard V, Moreau JF, Merville P, Déchanet-Merville J.

Front Immunol. 2015 Jan 21;6:3. doi: 10.3389/fimmu.2015.00003. eCollection 2015. Review.

25.

Chicago 2014--30 years of γδ T cells.

Bonneville M, Chen ZW, Déchanet-Merville J, Eberl M, Fournié JJ, Jameson JM, Lopez RD, Massaia M, Silva-Santos B.

Cell Immunol. 2015 Jul;296(1):3-9. doi: 10.1016/j.cellimm.2014.11.001. Epub 2014 Nov 8.

26.

Promising cell-based immunotherapy using gamma delta T cells: together is better.

Déchanet-Merville J.

Clin Cancer Res. 2014 Nov 15;20(22):5573-5. doi: 10.1158/1078-0432.CCR-14-1371. Epub 2014 Oct 2.

27.

Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.

Bachelet T, Couzi L, Pitard V, Sicard X, Rigothier C, Lepreux S, Moreau JF, Taupin JL, Merville P, Déchanet-Merville J.

J Am Soc Nephrol. 2014 Nov;25(11):2471-82. doi: 10.1681/ASN.2013101052. Epub 2014 Apr 17.

28.

New advances in CMV and immunosenescence.

Sansoni P, Vescovini R, Fagnoni FF, Akbar A, Arens R, Chiu YL, Cičin-Šain L, Dechanet-Merville J, Derhovanessian E, Ferrando-Martinez S, Franceschi C, Frasca D, Fulöp T, Furman D, Gkrania-Klotsas E, Goodrum F, Grubeck-Loebenstein B, Hurme M, Kern F, Lilleri D, López-Botet M, Maier AB, Marandu T, Marchant A, Matheï C, Moss P, Muntasell A, Remmerswaal EB, Riddell NE, Rothe K, Sauce D, Shin EC, Simanek AM, Smithey MJ, Söderberg-Nauclér C, Solana R, Thomas PG, van Lier R, Pawelec G, Nikolich-Zugich J.

Exp Gerontol. 2014 Jul;55:54-62. doi: 10.1016/j.exger.2014.03.020. Epub 2014 Apr 3.

29.

Enhancing production and cytotoxic activity of polymeric soluble FasL-based chimeric proteins by concomitant expression of soluble FasL.

Morello A, Daburon S, Castroviejo M, Moreau JF, Dechanet-Merville J, Taupin JL.

PLoS One. 2013 Aug 26;8(8):e73375. doi: 10.1371/journal.pone.0073375. eCollection 2013.

30.

Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma.

Devaud C, Rousseau B, Netzer S, Pitard V, Paroissin C, Khairallah C, Costet P, Moreau JF, Couillaud F, Dechanet-Merville J, Capone M.

Cancer Immunol Immunother. 2013 Jul;62(7):1199-210. doi: 10.1007/s00262-013-1402-1. Epub 2013 Apr 26.

PMID:
23619975
31.

Functional characterization of a chimeric soluble Fas ligand polymer with in vivo anti-tumor activity.

Daburon S, Devaud C, Costet P, Morello A, Garrigue-Antar L, Maillasson M, Hargous N, Lapaillerie D, Bonneu M, Dechanet-Merville J, Legembre P, Capone M, Moreau JF, Taupin JL.

PLoS One. 2013;8(1):e54000. doi: 10.1371/journal.pone.0054000. Epub 2013 Jan 9.

32.

Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor.

Willcox CR, Pitard V, Netzer S, Couzi L, Salim M, Silberzahn T, Moreau JF, Hayday AC, Willcox BE, Déchanet-Merville J.

Nat Immunol. 2012 Sep;13(9):872-9. doi: 10.1038/ni.2394. Epub 2012 Aug 12.

PMID:
22885985
33.

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.

Harly C, Guillaume Y, Nedellec S, Peigné CM, Mönkkönen H, Mönkkönen J, Li J, Kuball J, Adams EJ, Netzer S, Déchanet-Merville J, Léger A, Herrmann T, Breathnach R, Olive D, Bonneville M, Scotet E.

Blood. 2012 Sep 13;120(11):2269-79. doi: 10.1182/blood-2012-05-430470. Epub 2012 Jul 5.

34.

Harnessing γδ T cells in anticancer immunotherapy.

Hannani D, Ma Y, Yamazaki T, Déchanet-Merville J, Kroemer G, Zitvogel L.

Trends Immunol. 2012 May;33(5):199-206. doi: 10.1016/j.it.2012.01.006. Epub 2012 Feb 23.

PMID:
22364810
35.

Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa).

Couzi L, Pitard V, Sicard X, Garrigue I, Hawchar O, Merville P, Moreau JF, Déchanet-Merville J.

Blood. 2012 Feb 9;119(6):1418-27. doi: 10.1182/blood-2011-06-363655. Epub 2011 Dec 16.

36.

Control of Plasmodium falciparum erythrocytic cycle: γδ T cells target the red blood cell-invasive merozoites.

Costa G, Loizon S, Guenot M, Mocan I, Halary F, de Saint-Basile G, Pitard V, Déchanet-Merville J, Moreau JF, Troye-Blomberg M, Mercereau-Puijalon O, Behr C.

Blood. 2011 Dec 22;118(26):6952-62. doi: 10.1182/blood-2011-08-376111. Epub 2011 Nov 1.

37.

Gamma-delta T cell expansion is closely associated with cytomegalovirus infection in all solid organ transplant recipients.

Couzi L, Lafarge X, Pitard V, Neau-Cransac M, Dromer C, Billes MA, Lacaille F, Moreau JF, Merville P, Déchanet-Merville J.

Transpl Int. 2011 May;24(5):e40-2. doi: 10.1111/j.1432-2277.2010.01181.x. No abstract available.

38.

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.

Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, Lasarte JJ, Matsuzaki G, Ikuta K, Ryffel B, Benlagha K, Tesnière A, Ibrahim N, Déchanet-Merville J, Chaput N, Smyth MJ, Kroemer G, Zitvogel L.

J Exp Med. 2011 Mar 14;208(3):491-503. doi: 10.1084/jem.20100269. Epub 2011 Mar 7. Erratum in: J Exp Med. 2011 Apr 11:208(4):869.

39.

Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells.

Harly C, Peyrat MA, Netzer S, Déchanet-Merville J, Bonneville M, Scotet E.

Blood. 2011 Mar 10;117(10):2864-73. doi: 10.1182/blood-2010-09-309781. Epub 2011 Jan 13.

40.

Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients.

Faure-Della Corte M, Samot J, Garrigue I, Magnin N, Reigadas S, Couzi L, Dromer C, Velly JF, Déchanet-Merville J, Fleury HJ, Lafon ME.

J Clin Virol. 2010 Feb;47(2):161-9. doi: 10.1016/j.jcv.2009.11.023.

PMID:
20022297
41.

Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients.

Couzi L, Pitard V, Netzer S, Garrigue I, Lafon ME, Moreau JF, Taupin JL, Merville P, Déchanet-Merville J.

J Infect Dis. 2009 Nov 1;200(9):1415-24. doi: 10.1086/644509.

PMID:
19780672
42.

Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation.

Couzi L, Levaillant Y, Jamai A, Pitard V, Lassalle R, Martin K, Garrigue I, Hawchar O, Siberchicot F, Moore N, Moreau JF, Dechanet-Merville J, Merville P.

J Am Soc Nephrol. 2010 Jan;21(1):181-8. doi: 10.1681/ASN.2008101072. Epub 2009 Aug 27.

43.

Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model.

Devaud C, Bilhere E, Loizon S, Pitard V, Behr C, Moreau JF, Dechanet-Merville J, Capone M.

Cancer Res. 2009 May 1;69(9):3971-8. doi: 10.1158/0008-5472.CAN-08-3037. Epub 2009 Apr 21.

44.

UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients.

Garrigue I, Faure-Della Corte M, Magnin N, Recordon-Pinson P, Couzi L, Lebrette ME, Schrive MH, Roncin L, Taupin JL, Déchanet-Merville J, Fleury H, Lafon ME.

Transplantation. 2008 Sep 27;86(6):826-35. doi: 10.1097/TP.0b013e3181859edd.

PMID:
18813108
45.

Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection.

Pitard V, Roumanes D, Lafarge X, Couzi L, Garrigue I, Lafon ME, Merville P, Moreau JF, Déchanet-Merville J.

Blood. 2008 Aug 15;112(4):1317-24. doi: 10.1182/blood-2008-01-136713. Epub 2008 Jun 6.

46.

Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients.

Garrigue I, Corte MF, Magnin N, Couzi L, Capdepont S, Rio C, Merville P, Dechanet-Merville J, Fleury H, Lafon ME.

J Clin Virol. 2007 Oct;40(2):120-8. Epub 2007 Sep 10.

PMID:
17827058
47.

A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.

de Villartay JP, Lim A, Al-Mousa H, Dupont S, Déchanet-Merville J, Coumau-Gatbois E, Gougeon ML, Lemainque A, Eidenschenk C, Jouanguy E, Abel L, Casanova JL, Fischer A, Le Deist F.

J Clin Invest. 2005 Nov;115(11):3291-9.

48.

Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40.

Delmas Y, Viallard JF, Solanilla A, Villeneuve J, Pasquet JM, Belloc F, Dubus I, Déchanet-Merville J, Merville P, Blanco P, Pellegrin JL, Nurden AT, Combe C, Ripoche J.

Kidney Int. 2005 Nov;68(5):2068-78.

49.

[Platelet-associated CD154: a new interface in haemostasis and in the inflammatory reaction].

Delmas Y, Viallard JF, Villeneuve J, Grosset C, Pasquet JM, Déchanet-Merville J, Nurden P, Pellegrin JL, Rosenbaum J, Combe C, Nurden AT, Ripoche J.

Med Sci (Paris). 2005 Oct;21(10):825-31. Review. French.

50.

Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.

Halary F, Pitard V, Dlubek D, Krzysiek R, de la Salle H, Merville P, Dromer C, Emilie D, Moreau JF, Déchanet-Merville J.

J Exp Med. 2005 May 16;201(10):1567-78.

Supplemental Content

Loading ...
Support Center